Department of Endocrinology & Medicine, Pondicherry Institute of Medical Sciences, Puducherry, India.
Department of Endocrinology, Bharti Hospital, Karnal, Haryana, India.
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):55-62. doi: 10.1016/j.dsx.2020.11.014. Epub 2020 Nov 20.
The ongoing pandemic of coronavirus disease 2019 (COVID-19) is rapidly evolving, thereby posing a profound challenge to the global healthcare system. Cardiometabolic disorders are associated with poor clinical outcomes in persons with COVID-19. Healthcare challenges during the COVID-19 pandemic are linked to resource constraints including shortage of Personal Protective Equipment's (PPE), laboratory tests and medication. In this context, a group of clinical experts discussed the endocrine and cardiology vigilance required in times of COVID-19. Further, the group proposed certain resource husbandry recommendations to be followed during the pandemic to overcome the constraints.
The clinical experts discussed and provided their inputs virtually. The expert panel included clinical experts comprising endocrinologists, Consultant Physicians and cardiologists from India. The panel thoroughly reviewed existing literature on the subject and proposed expert opinion.
The expert panel put forward clinical practice-based opinion for the management of cardiometabolic conditions including diabetes mellitus and hypertension. As these conditions are associated with poor clinical outcomes, the expert panel recommends that these persons be extra-cautious and take necessary precautions during the ongoing pandemic. Further, experts also provided appropriate, affordable, available and accessible solution to the resource constraint situations in times of COVID-19 pandemic.
The clinical expert opinion put forward in this article will serve as a reference for clinicians treating diabetes and cardiovascular disease during the COVID-19 pandemic.
目前,2019 年冠状病毒病(COVID-19)大流行正在迅速发展,这对全球医疗保健系统构成了深远挑战。心血管代谢疾病与 COVID-19 患者的临床预后不良有关。COVID-19 大流行期间的医疗保健挑战与资源限制有关,包括个人防护设备(PPE)、实验室检测和药物短缺。在这种情况下,一组临床专家讨论了 COVID-19 期间需要进行内分泌和心脏病学监测。此外,该小组提出了在大流行期间应遵循的某些资源管理建议,以克服这些限制。
临床专家在线上进行了讨论并提供了意见。专家组包括来自印度的内分泌学家、顾问医师和心脏病专家等临床专家。该小组彻底审查了关于该主题的现有文献,并提出了专家意见。
专家组就包括糖尿病和高血压在内的心血管代谢疾病的管理提出了基于临床实践的意见。由于这些疾病与临床预后不良有关,专家组建议这些患者在当前大流行期间格外小心并采取必要的预防措施。此外,专家还针对 COVID-19 大流行期间的资源限制情况提供了适当、负担得起、可获得和可及的解决方案。
本文提出的临床专家意见将为在 COVID-19 大流行期间治疗糖尿病和心血管疾病的临床医生提供参考。